Daniel Brie

Daniel Brie
Cardiovasculare Disease Instiute Timisoara · Interventional Cardiology

MD

About

7
Publications
1,546
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
76
Citations

Publications

Publications (7)
Article
INTRODUCTION: Pentoxifylline is a xanthine derivative with several potential cardiovascular (CV) benefits, but the evidence regarding its effects on blood pressure (BP) and inflammatory markers such as tumor necrosis factor (TNF-α), C-reactive protein (CRP) and interleukin-6 (IL-6) is not conclusive. PURPOSE: To evaluate the impact of pentoxifylli...
Article
INTRODUCTION: Pentoxifylline is a xanthine derivative with several potential cardiovascular (CV) benefits, but the evidence regarding its effects on blood pressure (BP) and inflammatory markers such as tumor necrosis factor (TNF-α), C-reactive protein (CRP) and interleukin-6 (IL-6) is not conclusive. PURPOSE: To evaluate the impact of pentoxifylli...
Article
Introduction: Pentoxifylline is a xanthine derivative with potential cardiovascular benefits. Aim: To evaluate the impact of pentoxifylline on blood pressure and plasma tumor necrosis factor-α, C-reactive protein and interleukin-6 through a systematic review and meta-analysis of randomized controlled trials. Methods: The protocol was registered (P...
Article
Today, drug-eluting metal stents are considered the gold standard for interventional treatment of coronary artery disease. While providing inhibition of neointimal hyperplasia, drug-eluting metal stents have many limitations such as the risk of late and very late stent thrombosis, restriction of vascular vasomotion and chronic local inflammatory re...
Article
Background: Several studies suggest similar clinical outcomes between everolimus-eluting bioresorbable stents (BRS) ABSORB (Abbott Vascular, Santa Clara, CA) versus conventional drug-eluting stents (DES) and bare metallic stents (BMS), but the evidence is not definitive. We performed a systematic review and meta-analysis to investigate the effects...
Article
Full-text available
AIMS: Several studies suggest good procedural and similar clinical outcomes between everolimus-eluting bioresorbable stents (BRS) ABSORB versus conventional drug-eluting stents (DES), but the evidence is not definitive. We performed a systematic review and meta-analysis to investigate the effects of BRS versus conventional drug eluting and bare met...
Article
Purpose. Our purpose was to study certain conventional echocardiographic parameters, before and after cardiac resynchronization therapy, in order to establish their importance in the evaluation of therapy results and to create an efficient and non time-consuming patient evaluation protocol. Materials and methods. The standard echocardiographic para...

Projects

Project (1)
Project
LBPMC Group was founded by Professor Maciej Banach in 2012 as a worldwide network of experts in the field of lipid disorders, hypertension, risk stratification and preventive cardiology. The main aim of the Group is to answer the questions on the most debatable issues and recent challenges in the abovementioned areas. The 2nd aim is to extend this collaboration into Data Management and Processing Centre (DMPC) - the largest patients' data analysing centre in Europe. Currently over 100 experts are involved in the collaboration within LBPMC Group. For more please see: http://lbpmcgroup.umed.pl